Live Quote · NASDAQGILDHealthcare· Drug Manufacturers - General

Gilead Sciences, Inc.

$166.43▼ 0.06%($-0.10)
MKT CAP $206.43BNEXT EARNINGS Feb 9, 2027
50%
Bullish
TickerSpark Score
65/100
▌ Solid
56
Valuation
40
Profitability
70
Growth
60
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GILD research report →

Analyst Price Target
$167.47+0.6% vs. today

Range $126 – $196

Analyst RatingBuy
38 Buy19 Hold1 Sell

Price Chart

+33.15% · this period
$174.48$146.39$118.30Nov 20May 26Nov 20
52-Week Range83% of range
Low
$116.88
Current
$166.43
High
$176.58